Psychotherapeutic Drugs

Before beginning a patient's therapy with selective serotonin reuptake inhibitor (SSRI) antidepressants, the nurse will assess for concurrent use of warfarin. Warfarin's interaction with SSRIs can lead to an increased risk of bleeding due to the potential for SSRIs to affect platelet function and coagulation. Monitoring for this combination is essential to ensure patient safety and minimize adverse effects during treatment. A: Aspirin Aspirin does not have a significant interaction with SSRIs that necessitates careful monitoring, making it less critical in this context. C: Diuretics Diuretics do not interact directly with SSRIs in a way that warrants specific assessment prior to therapy initiation. D: Nonsteroidal anti-inflammatory drugs Nonsteroidal anti-inflammatory drugs can cause gastrointestinal issues but are not specifically contraindicated with SSRIs, thus reducing their relevance in this assessment.

Decreased paranoia and delusions. Second-generation antipsychotics like risperidone effectively target positive symptoms of schizophrenia, including paranoia and delusions, leading to significant improvements in the patient’s mental state and overall functioning. A: Fewer panic attacks. Second-generation antipsychotics primarily address psychotic symptoms rather than anxiety disorders, so they do not directly reduce panic attacks in patients. C: Decreased feeling of hopelessness. While some mood improvement may occur, second-generation antipsychotics mainly focus on psychotic symptoms rather than addressing feelings of hopelessness directly. D: Improved tardive dyskinesia. Second-generation antipsychotics are less likely to cause tardive dyskinesia, but they do not improve existing cases; instead, they might still pose a risk for such side effects.

Involuntary motor symptoms. Haloperidol, an antipsychotic, can lead to extrapyramidal symptoms, which include tremors, rigidity, and other involuntary movements, making monitoring for these effects crucial in managing the patient's treatment. A: Increased paranoia. While psychotic disorders can manifest paranoia, haloperidol is typically used to reduce such symptoms rather than exacerbate them, making this choice irrelevant in the context of extrapyramidal monitoring. B: Drowsiness and dizziness. Although sedation can occur with antipsychotic medications, these effects are not classified as extrapyramidal symptoms, thus not the primary concern for this specific monitoring focus. D: Dry mouth and constipation. These are common side effects of antipsychotics but do not relate to extrapyramidal symptoms, which specifically involve abnormal involuntary movements and motor control issues.

You need to avoid all foods that contain tyramine, including beer, while taking this medication. Consuming tyramine while on phenelzine can lead to severe hypertensive crises, which are dangerous and can cause serious health issues. Therefore, the patient must completely avoid beer to ensure safety while undergoing treatment with this MAOI. A: You can drink beer as long as you have a designated driver. This suggestion ignores the critical interaction between tyramine in beer and MAOIs, which can cause serious health complications. B: Now that you've been on the drug for 6 months, there will be no further dietary restrictions. This statement is misleading; dietary restrictions regarding tyramine are ongoing for patients on MAOIs regardless of treatment duration. C: If you begin to experience a throbbing headache, rapid pulse, or nausea, you'll need to stop drinking. This advice is reactive rather than preventive; avoiding tyramine altogether is essential to prevent these symptoms from occurring.

A patient’s lithium level of 0.5 mEq/L is too low, indicating a subtherapeutic dose. This raises concerns about the potential for ineffective treatment of their condition, necessitating dosage adjustments to achieve the desired therapeutic effect. B: The level is within the therapeutic range. A lithium level of 0.5 mEq/L is below the generally accepted therapeutic range of 0.6 to 1.2 mEq/L, thus ineffective. C: The level is too high, indicating a toxic dose. A level of 0.5 mEq/L does not suggest toxicity; toxic levels are significantly higher, often above 1.5 mEq/L. D: No concerns, as lithium levels do not need monitoring. Regular monitoring of lithium levels is crucial for effective treatment and to prevent adverse effects, contrary to this option's implication.

Dry mouth is a common adverse effect of phenothiazine drugs used to treat schizophrenia, often resulting from anticholinergic properties that reduce saliva production, leading to discomfort and difficulty speaking or swallowing. A: I can't sleep at night. Sleep disturbances are not directly associated with phenothiazines but may arise from other factors, such as underlying psychiatric conditions or medication side effects unrelated to the drug class. B: I feel hungry all the time. Increased appetite is not a typical adverse effect of phenothiazines; rather, these medications are more commonly linked to weight gain due to metabolic changes over time. C: Look at how red my hands are. Redness or flushing of the hands does not correlate with phenothiazine use and may indicate another condition, such as an allergic reaction or vascular issue unrelated to the medication.

Taking St. John's wort with this medication may cause severe interactions and is not recommended. Combining St. John's wort with sertraline can lead to serotonin syndrome, a potentially life-threatening condition due to excessive serotonin levels. The nurse must prioritize patient safety by advising against this herbal therapy, highlighting the risk of adverse effects rather than assuming compatibility with the current treatment. A: That should be no problem. This response overlooks the serious potential interactions between St. John's wort and sertraline, compromising patient safety and failing to address the risks involved. B: Good idea! Hopefully you'll be able to stop taking the Zoloft. This suggestion is reckless, as it encourages the patient to reduce or discontinue prescribed medication without considering possible negative consequences or necessary medical oversight. C: Be sure to stop taking the herb if you notice a change in side effects. This response inadequately addresses the urgency of preventing interactions, suggesting a reactive approach rather than a proactive caution against combining the two substances.

Self-injury or suicidal tendencies. During the initial stages of SSRI therapy, there's an increased risk of suicidal thoughts or behaviors, particularly in younger patients, necessitating close monitoring for any signs of self-harm. A: Hypertensive crisis. This condition is typically associated with MAOIs and not SSRIs, as SSRIs do not cause significant increases in blood pressure during the early phase of treatment. C: Extrapyramidal symptoms. While these symptoms can occur with certain psychiatric medications, they are not commonly associated with SSRIs, making this option irrelevant for early SSRI therapy monitoring. D: Loss of appetite. Although SSRIs can affect appetite, loss of appetite is not a primary concern during the early phases of treatment compared to the risk of suicidal tendencies.

Cardiac dysrhythmias are the immediate concern when a patient is suspected of a tricyclic antidepressant overdose. These medications can significantly affect cardiac conduction, leading to potentially life-threatening arrhythmias that require prompt intervention. A: Hypertension may occur but is not a primary immediate concern in tricyclic overdoses, where cardiac issues predominantly arise. B: Renal failure is a potential complication of various overdoses, yet it is not an immediate risk in the context of tricyclic antidepressant toxicity. D: Gastrointestinal bleeding can happen with overdoses but is not an urgent threat compared to the critical risk of cardiac dysrhythmias associated with tricyclic antidepressants.

It may take 4 to 6 weeks to notice any therapeutic effects. Let's wait a little longer to see how he does. The context emphasizes the typical timeline for antidepressants to exhibit noticeable benefits. This response informs the wife that patience is necessary, reinforcing the treatment's gradual nature and preventing premature conclusions about its effectiveness. A: The medication may not be effective for him. This suggests an immediate failure of the current treatment, disregarding the essential waiting period for medications to demonstrate their full impact. C: It sounds like the dose is not high enough. This implies an assumption about dosage without considering the initial treatment phase, potentially leading to unnecessary adjustments before the medication has had adequate time to work. D: Some patients never recover from depression. This statement presents a bleak outlook that may discourage hope and does not acknowledge the possibility of positive treatment outcomes with time and appropriate intervention.

Severe neutropenia. Monitoring for this adverse effect is crucial with clozapine therapy, as it can lead to life-threatening infections due to significantly reduced white blood cell counts, necessitating regular blood tests to ensure safety. A: Edema. While clozapine may lead to weight gain, edema is not a commonly monitored or reported adverse effect, making it less relevant in this context. B: Photosensitivity. Clozapine does not typically cause photosensitivity reactions, which are more associated with other medications, thereby making it an unlikely concern during therapy. C: Hypotension. Although clozapine may cause hypotension, it is not the primary adverse effect of concern compared to severe neutropenia, which poses a more immediate health risk.

B: Salami sandwich. Salami contains tyramine, which can trigger hypertensive crises in patients taking MAOIs, making it a food choice that necessitates further education to ensure patient safety. A: Grapefruit juice. While grapefruit juice can interact with certain medications, it does not pose a significant risk for patients on MAOIs and is generally considered safe. C: Scrambled eggs. Eggs are low in tyramine and are typically safe for patients on MAOIs, making them a suitable food option without the need for additional caution. D: Pancakes and maple syrup. Both pancakes and maple syrup are low in tyramine, posing no significant risk for patients on MAOIs and therefore do not require further teaching.

Palpitations and anxiety. Ginseng is known to stimulate the central nervous system, which can lead to increased heart rate and feelings of anxiety in some individuals, making this a notable potential adverse effect. A: Drowsiness. Ginseng typically acts as a stimulant, which is more likely to cause alertness rather than drowsiness, contradicting the expected effects of this herb. C: Dry mouth. While some supplements can cause dry mouth, ginseng is not commonly associated with this symptom, making it an unlikely adverse effect for users. D: Constipation. Ginseng does not generally affect bowel movements, and constipation is not a common side effect, thus it is not a significant concern with ginseng use.

Selective serotonin reuptake inhibitors (SSRIs) are more widely prescribed today than tricyclic antidepressants due to the serious cardiac dysrhythmias that can occur with overdose of tricyclics. SSRIs are preferred as they have a safer overdose profile, significantly reducing the risk of life-threatening cardiac issues, making them a more favorable choice for both patients and healthcare providers. A: SSRIs have fewer sexual side effects. While SSRIs typically have fewer sexual side effects than tricyclics, this does not encompass the critical aspect of overdose safety that drives prescription preferences. B: Unlike tricyclic antidepressants, SSRIs do not have drug-food interactions. Though SSRIs have fewer interactions, the primary concern impacting prescription rates hinges on the severe consequences of tricyclic overdoses rather than dietary issues. D: SSRIs cause a therapeutic response faster than tricyclic antidepressants. Although SSRIs may yield quicker effects, the paramount factor influencing their prescription is the reduced risk of serious complications associated with tricyclic overdoses.

Agitation, tremors, and sweating are symptoms of serotonin syndrome. These manifestations occur due to excessive serotonin levels in the brain, often triggered by interactions between SSRIs and herbal products like St. John’s wort. B: Drowsiness Drowsiness does not typically align with serotonin syndrome, which is characterized by heightened arousal and increased sympathetic activity rather than sedation or lethargy. D: Bradycardia Bradycardia, a slowed heart rate, contrasts with the more common tachycardia seen in serotonin syndrome, reflecting the overstimulation of the central nervous system rather than a depressed state.

Therapeutic effects may not be seen for about 4 to 6 weeks after the medication is started. SSRIs work gradually, influencing serotonin levels over time, which explains the delayed onset of therapeutic benefits for patients. A: Avoid foods and beverages that contain tyramine. SSRIs do not require dietary restrictions related to tyramine, as this concern is primarily associated with monoamine oxidase inhibitors (MAOIs). B: Monitor the patient for extrapyramidal symptoms. Extrapyramidal symptoms are typically linked to antipsychotic medications rather than SSRIs, which have a different side effect profile. E: These drugs have anticholinergic effects, including constipation, urinary retention, dry mouth, and blurred vision. SSRIs generally have a lower incidence of anticholinergic effects compared to tricyclic antidepressants, making this statement misleading. F: Cogentin is often also prescribed to reduce the adverse effects that may occur. Cogentin is used primarily for antipsychotic-induced symptoms, not for SSRIs, which do not commonly require such adjunctive treatment.

0.5 mL To achieve a 1 mg dose of lorazepam from a solution of 2 mg/mL, the nurse calculates the volume by dividing the desired dose by the concentration, resulting in 0.5 mL. A: 1 mL The calculation of 1 mL would provide 2 mg of lorazepam, exceeding the prescribed dose, which could lead to potential adverse effects for the patient. B: 0.25 mL Calculating 0.25 mL yields only 0.5 mg of lorazepam, which is insufficient to meet the required dose of 1 mg for effective therapeutic action. C: 2 mL Administering 2 mL would result in a 4 mg dose of lorazepam, significantly surpassing the intended dosage and increasing the risk of overdose complications.